Victoria, British Columbia Thursday, November 14, 2024, 18:00 Hrs [IST] ...

One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

With a diverse drug portfolio and a robust pipeline of future drugs to market, this big pharma brand will play a major role ...

The Series D financing will support the clinical development of two ADCs.

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

As the demand for localized treatment options continues to rise ... Smart Pills Market Size By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), By Target Area (Esophagus, Small ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

The Western medical establishment ousted him. China embraced him. Will the man on a mission to perform the first human head ...

Diagnosed in 2021, Perry Newman, who is originally from Englee, is fundraising to raise enough money to participate in a ...